109 related articles for article (PubMed ID: 21355526)
1. Synthesis and LAR inhibition of 7-alkoxy analogues of illudalic acid.
Ling Q; Zhou YY; Cai ZL; Zhang YH; Xiong B; Ma LP; Wang X; Li X; Li J; Shen JK
Yao Xue Xue Bao; 2010 Nov; 45(11):1385-97. PubMed ID: 21355526
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and PTP Inhibitory Activity of Illudalic Acid and Its Methyl Ether, with Insights into Selectivity for LAR PTP over Other Tyrosine Phosphatases under Physiologically Relevant Conditions.
McCullough BS; Batsomboon P; Hutchinson KB; Dudley GB; Barrios AM
J Nat Prod; 2019 Dec; 82(12):3386-3393. PubMed ID: 31809044
[TBL] [Abstract][Full Text] [Related]
3. Illudalic acid as a potential LAR inhibitor: synthesis, SAR, and preliminary studies on the mechanism of action.
Ling Q; Huang Y; Zhou Y; Cai Z; Xiong B; Zhang Y; Ma L; Wang X; Li X; Li J; Shen J
Bioorg Med Chem; 2008 Aug; 16(15):7399-409. PubMed ID: 18579388
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of covalent inhibition of LAR phosphatase by illudalic acid.
Hansen DT; Rueb NJ; Levinzon ND; Cheatham TE; Gaston R; Tanvir Ahmed K; Osburn-Staker S; Cox JE; Dudley GB; Barrios AM
Bioorg Med Chem Lett; 2024 May; 104():129740. PubMed ID: 38599294
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity studies of PTPRD phosphatase inhibitors identify a 7-cyclopentymethoxy illudalic acid analog candidate for development.
Henderson IM; Zeng F; Bhuiyan NH; Luo D; Martinez M; Smoake J; Bi F; Perera C; Johnson D; Prisinzano TE; Wang W; Uhl GR
Biochem Pharmacol; 2022 Jan; 195():114868. PubMed ID: 34863978
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, biological evaluation and molecular dynamics of LAR inhibitors.
Sun YZ; Wu JW; Du S; Ma YC; Zhou L; Ma Y; Wang RL
Comput Biol Chem; 2021 Jun; 92():107481. PubMed ID: 33838390
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potent inhibitors of receptor protein tyrosine phosphatase sigma through the structure-based virtual screening.
Park H; Chien PN; Ryu SE
Bioorg Med Chem Lett; 2012 Oct; 22(20):6333-7. PubMed ID: 22989533
[TBL] [Abstract][Full Text] [Related]
8. Coumarin sulfonates: New alkaline phosphatase inhibitors; in vitro and in silico studies.
Salar U; Khan KM; Iqbal J; Ejaz SA; Hameed A; Al-Rashida M; Perveen S; Tahir MN
Eur J Med Chem; 2017 May; 131():29-47. PubMed ID: 28288318
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel protein tyrosine phosphatase sigma inhibitors promoting neurite extension.
Lee HS; Ku B; Park TH; Park H; Choi JK; Chang KT; Kim CH; Ryu SE; Kim SJ
Bioorg Med Chem Lett; 2016 Jan; 26(1):87-93. PubMed ID: 26602279
[TBL] [Abstract][Full Text] [Related]
10. Divalent and trivalent alpha-ketocarboxylic acids as inhibitors of protein tyrosine phosphatases.
Chen YT; Seto CT
J Med Chem; 2002 Aug; 45(18):3946-52. PubMed ID: 12190316
[TBL] [Abstract][Full Text] [Related]
11. Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4'-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11β-hydroxylase.
Stefanachi A; Hanke N; Pisani L; Leonetti F; Nicolotti O; Catto M; Cellamare S; Hartmann RW; Carotti A
Eur J Med Chem; 2015 Jan; 89():106-14. PubMed ID: 25462231
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Sun LP; Gao LX; Ma WP; Nan FJ; Li J; Piao HR
Chem Biol Drug Des; 2012 Oct; 80(4):584-90. PubMed ID: 22805439
[TBL] [Abstract][Full Text] [Related]
13. Substituted coumarins as potent 5-lipoxygenase inhibitors.
Grimm EL; Brideau C; Chauret N; Chan CC; Delorme D; Ducharme Y; Ethier D; Falgueyret JP; Friesen RW; Guay J; Hamel P; Riendeau D; Soucy-Breau C; Tagari P; Girard Y
Bioorg Med Chem Lett; 2006 May; 16(9):2528-31. PubMed ID: 16464579
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of a potent and selective protein tyrosine phosphatase inhibitor, 2.
Hamaguchi T; Takahashi A; Kagamizono T; Manaka A; Sato M; Osada H
Bioorg Med Chem Lett; 2000 Dec; 10(23):2657-60. PubMed ID: 11128645
[TBL] [Abstract][Full Text] [Related]
15. [Design, synthesis and evaluation of malonic acid-based PTP1B inhibitors].
Du X; Zhang SE; Liu JZ; Nie FL; Ye F; Tian JY; Xiao ZY
Yao Xue Xue Bao; 2012 Mar; 47(3):367-73. PubMed ID: 22645761
[TBL] [Abstract][Full Text] [Related]
16. Novel Imbricatolic acid derivatives as protein tyrosine phosphatase-1B inhibitors: Design, synthesis, biological evaluation and molecular docking.
Khan MF; Azad CS; Kumar A; Saini M; Narula AK; Jain S
Bioorg Med Chem Lett; 2016 Apr; 26(8):1988-92. PubMed ID: 26965864
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of illudalic acid and analogous phosphatase inhibitors.
Fulo HF; Rueb NJ; Gaston R; Batsomboon P; Ahmed KT; Barrios AM; Dudley GB
Org Biomol Chem; 2021 Dec; 19(48):10596-10600. PubMed ID: 34847212
[TBL] [Abstract][Full Text] [Related]
18. Novel thiophene derivatives as PTP1B inhibitors with selectivity and cellular activity.
Ye D; Zhang Y; Wang F; Zheng M; Zhang X; Luo X; Shen X; Jiang H; Liu H
Bioorg Med Chem; 2010 Mar; 18(5):1773-82. PubMed ID: 20153651
[TBL] [Abstract][Full Text] [Related]
19. Identification of small molecule inhibitors of PTPσ through an integrative virtual and biochemical approach.
Martin KR; Narang P; Xu Y; Kauffman AL; Petit J; Xu HE; Meurice N; MacKeigan JP
PLoS One; 2012; 7(11):e50217. PubMed ID: 23185579
[TBL] [Abstract][Full Text] [Related]
20. Investigations of linker structure on the potency of a series of bidentate protein tyrosine phosphatase inhibitors.
Xie J; Seto CT
Bioorg Med Chem; 2005 Apr; 13(8):2981-91. PubMed ID: 15781408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
